Suchergebnisse - "O3J8G9O825"

PubPharm (70)

1

Prevalence and risk factors of metabolic syndrome in Ethiopia : describing an emerging outbreak in HIV clinics of the sub-Saharan Africa - a cross-sectional study

enthalten in: BMJ open | 2023

von Abdela, A. | Yifter, H. | Reja, A. | +3

2

Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda

enthalten in: Clinical pharmacology and therapeutics | 2023

von Kay, K. | Goodwin, J. | Ehrlich, H. | +13

3

Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens

enthalten in: AIDS (London, England) | 2022

von van Zyl, G. | Jennings, L. | Kellermann, T. | +7

4

Risk Factors for Incident Hypertension Within 1 Year of Initiating Antiretroviral Therapy Among People with HIV

enthalten in: AIDS research and human retroviruses | 2022

von Siddiqui, M. | Moore, T. | Long, D. | +6

5

A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis Treatment

enthalten in: Clinical pharmacology and therapeutics | 2021

von Francis, J. | Mngqibisa, R. | McIlleron, H. | +8

6

Efavirenz, atazanavir, and ritonavir disrupt sarcoplasmic reticulum Ca2+ homeostasis in skeletal muscles

enthalten in: Antiviral research | 2021

von Alomar, F. | Tian, C. | Dash, P. | +4

7

Bone turnover markers in children living with HIV remaining on ritonavir-boosted lopinavir or switching to efavirenz

enthalten in: Bone | 2020

von Shiau, S. | Yin, M. | Strehlau, R. | +5

8

Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives

enthalten in: Pharmacogenetics and genomics | 2020

von Haas, D. | Cramer, Y. | Godfrey, C. | +12

9

Antiretroviral therapy and vaginally administered contraceptive hormones : a three-arm, pharmacokinetic study

enthalten in: The lancet. HIV | 2019

von Scarsi, K. | Cramer, Y. | Rosenkranz, S. | +31

CommentIn: Lancet HIV. 2019 Sep;6(9):e561-e563. - PMID 31371261

10

Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Bednasz, C. | Venuto, C. | Ma, Q. | +10

1
2
3
4
5
6
7
Nächster »
[7]